Rethinking Clinical Trials

OCTOBER 31, 2023

Does it capture most what matters to patients? Pfizer provided feedback. Tags #pctGR, @Collaboratory1 The post Grand Rounds October 27, 2023: Digital, Decentralized and Democratized: Lessons From The Yale PaxLC Trial (Harlan M. We had to come up with solutions. We wanted to measure a lot of stuff.

Trials 228

Trials Medicine Research Clinical Trials 228

Rethinking Clinical Trials

NOVEMBER 21, 2023

The Nudge study wanted to find out if nudges could help patients improve medication adherence by promoting behavioral change through positive reinforcement. The Year 1, UG3 Phase, aims were to develop and program a nudge message library using iterative N of 1 studies to optimize content for a range of diverse patients.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Development 141

Rethinking Clinical Trials

AUGUST 30, 2023

   Speaker Gabriela Schmajuk, MD, MS Professor of Medicine UCSF and the San Francisco VA Slides Keywords Patient-Reported Outcomes, Rheumatoid Arthritis, EHR Key Points Clinicians rely on patient-related outcomes (PROs) to track disease and function over time in patients with rheumatoid arthritis (RA).

Trials 141

Trials Clinical Research Coordinator Medicine Clinical Trials 141

Rethinking Clinical Trials

FEBRUARY 2, 2023

There are many choices clinicians must make for every emergency tracheal intubation for which the effect on patient outcomes is unknown. There was a 1-page data collection sheet that trained site-specific observers completed with rapid feedback from research team on data quality. This results in arbitrary variation in clinical care.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Rethinking Clinical Trials

JULY 19, 2023

The intervention included assessment of local practices and barriers, development of strategies to overcome those barriers, and audit and feedback of quality metrics, with the goal of improving the way clinics approach treatment of these diseases. of the patients ended up being prescribed all 3 therapies, and 37.9%

Trials 130

Trials Cardiology Medicine Nurses 130

Delveinsight

FEBRUARY 23, 2021

The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform. BrainStorm Receives Feedback on BLA Submission for ALS. Libtayo for First-line Advanced Non-small Cell Lung Cancer Subset.

In-Vitro 52

In-Vitro Vaccination Vaccine Licensing 52

pharmaphorum

SEPTEMBER 15, 2020

The huge rise in the use of telemedicine services during lockdown has brought care directly to patients in their homes, while pharma’s communications with healthcare professionals (HCPs) has experienced a similar push to digital channels. Jeremy Richter, Tag. We’re all trying to find ways to automate. About the interviewees.

Branding 130

Branding Marketing Pharma Companies Life Science 130